Improved therapies for atrial fibrillation on the horizon
Approximately 2.5 million people in the U.S. have atrial fibrillation (AF), and more than 10% are older than 80 years old, said Kevin Donahue, MD, an assistant professor of medicine at Johns Hopkins University School of Medicine in Baltimore, Md. AF increases the risk of stroke 5-fold and is responsible for 15% to 20% of strokes every year, he said. AF also increases the risk of congestive heart failure: among those with congestive heart failure, 10% to 30% have AF, he continued. "There is a tremendous need for innovative approaches to the treatment of this life-threatening condition," Donahue concluded. Donahue spoke about new research in AF at a recent American Medical Association media briefing held in New York City. Funding for the event was provided by an unrestricted educational grant from Johnson & Johnson.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
